MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 06-06-2026
Covetrus ROE Ratio 2011-2026 | CVET
Annual ROE Ratio Covetrus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.57 | -1.24 | -78.21 | 6.96 | 5.27 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.96 | -78.21 | -14.16 |
Quarterly ROE Ratio Covetrus
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.66 | -0.66 | -2.73 | -3.51 | -3.38 | -3.64 | -5.85 | 0.45 | -1.25 | -3.94 | -69.64 | -74.31 | -72.14 | -66.91 | 2.33 | 4.72 | 6.83 | 1.07 | 1.94 | 1.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.83 | -74.31 | -14.49 |
ROE Ratio of other stocks in the Health information services industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
15.1 | - | - | $ 27.9 B |  USA |
 |
Accolade
ACCD
|
-22.4 | - | 0.29 % | $ 206 M | USA |
 |
Evolent Health
EVH
|
-139.55 | $ 4.62 | -3.75 % | $ 528 M | USA |
 |
HealthEquity
HQY
|
10.21 | $ 86.34 | -2.27 % | $ 7.44 B | USA |
 |
Change Healthcare
CHNG
|
-1.75 | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
2.45 | - | 4.4 % | $ 133 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-50.2 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
7.4 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
3.19 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
-19.58 | - | - | $ 102 M | USA |
 |
GoodRx Holdings
GDRX
|
4.93 | $ 2.69 | 1.32 % | $ 959 M | USA |
 |
Akerna Corp.
KERN
|
-23.01 | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
-36.26 | - | -10.39 % | $ 886 M | USA |
 |
10x Genomics
TXG
|
-5.47 | $ 30.98 | 7.42 % | $ 3.86 B | USA |
 |
MTBC
MTBC
|
0.02 | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
-25.77 | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
-0.66 | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
1.17 | - | - | $ 2.33 B | USA |
 |
Health Catalyst
HCAT
|
-72.41 | $ 1.76 | -4.86 % | $ 123 M | USA |
 |
OptimizeRx Corporation
OPRX
|
4.0 | $ 5.25 | 0.38 % | $ 97.4 M | USA |
 |
Schrödinger
SDGR
|
-28.37 | $ 14.6 | 1.04 % | $ 1.07 B | USA |
 |
Phreesia
PHR
|
0.68 | $ 9.1 | 0.44 % | $ 544 M | USA |
 |
R1 RCM
RCM
|
28.04 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
-14.46 | $ 7.44 | 1.29 % | $ 1.31 B | USA |
 |
Signify Health
SGFY
|
-70.29 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-82.75 | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
30.07 | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
-62.13 | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
-40.62 | $ 9.17 | 0.66 % | $ 147 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
258.65 | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
5.18 | $ 25.93 | -0.78 % | $ 778 M | USA |
 |
Omnicell
OMCL
|
0.17 | $ 38.59 | 2.0 % | $ 1.77 B | USA |
 |
Progyny
PGNY
|
11.34 | $ 26.71 | 0.3 % | $ 2.28 B | USA |
 |
So-Young International
SY
|
-15.6 | $ 1.84 | -1.02 % | $ 143 M |  China |
 |
Veeva Systems
VEEV
|
12.6 | $ 164.09 | 2.85 % | $ 26.9 B | USA |
 |
Zhongchao
ZCMD
|
-33.87 | $ 0.63 | -2.29 % | $ 2.15 M | China |